Irene Burckhardt

Dr. Irene Burckhardt

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
IBIrene Burckhardt
Irene Burckhardt
SZStefan Zimmermann
Stefan Zimmermann
In recent years, the percentage of carbapenem-resistant bacteria has increased at an alarming pace and become a major threat for patient survival. Carbapenemase-induced carbapenem resistance can be confirmed through the detection of carbapenem degradation using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). This method works for strains carrying NDM-1, VIM-1, VIM-2, KPC-2, and different IMP enzymes.

10 September 2008 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
MRMaria J. G. T. Rüping
Maria J. G. T. Rüping
NANadine Albermann
Nadine Albermann
FEFriedrich Ebinger
Friedrich Ebinger
IBIrene Burckhardt
Irene Burckhardt
CBClaudia Beisel
Claudia Beisel
OCOliver A. Cornely
Oliver A. Cornely
M. K. has been a consultant for Pfizer, Eli Lilly and Roche. G. F. has been a consultant for Schering Plough, Pfizer and Gilead, has served on a speaker's burea

6 August 2018 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
IBIrene Burckhardt
Irene Burckhardt
SZStefan Zimmermann
Stefan Zimmermann
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) was introduced into the microbiological routine more than 10 years ago. Since then it has almost replaced biochemical identification. It is unrivaled in terms of accuracy and cost. From a laboratory's perspective it would be an ideal method to replace classic susceptibility testing, that is Kirby-Baur agardiffusion or determination of minimal inhibitory concentrations (MICs). First reports on possible assays for susceptibility testing are more than 10 years old. However, the developments during the last 5 years were substantial. This review focuses with some exceptions on the progress, which was achieved during the last decade.

1 September 2016 in International Journal of Medical Microbiology
Verified
Journal Article
Closed access
MKMartin Kaase
Martin Kaase
SSSven Schimanski
Sven Schimanski
RSReinhold Schiller
Reinhold Schiller
BBBettina Beyreiß
Bettina Beyreiß
ATAlexander Thürmer
Alexander Thürmer
SGSören G. Gatermann
Sören G. Gatermann

28 February 2020 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
PDF file
JJJasmin Kaur Jasuja
Jasmin Kaur Jasuja
SZStefan Zimmermann
Stefan Zimmermann
IBIrene Burckhardt
Irene Burckhardt
Our objective was to evaluate EUCAST’s ‘rapid antimicrobial susceptibility testing’ (RAST) directly from positive blood culture that delivers antimicrobial results within 6 h for Staphylococcus aureus, Enterococcus spp., Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa, using total lab automation. Zone diameters from RAST were compared with MIC results. Furthermore, its influence on time to report was investigated. RAST was performed to all positive aerobic and anaerobic blood culture bottles by subculturing them, i.e. onto Mueller-Hinton agar and adding six antibiotic discs covering Gram-negative and Gram-positive therapy (cefoxitin, ampicillin, vancomycin, piperacillin/tazobactam, meropenem and ciprofloxacin). RAST was automatically imaged after 6 h. Zone sizes were measured using a TLA software tool and interpreted according to EUCAST clinical breakpoints. Bacteria were identified using MALDI-TOF MS and MIC results were determined using Vitek2 panels. Categorial agreement between agar diffusion and MIC results was investigated. Additionally, time to RAST and time to Vitek were compared for 100 isolates (20 per species). Between November 2018 and April 2019, 3313 positive mono-bacterial blood culture bottles were collected of which 894 bottles with RAST-validated species were investigated. Among these bottles, 2029 individual antibiotic measurements were compared with MIC results from Vitek2 and 14 very major, 28 major and 12 minor errors were found. A median reduction of 17:30 h in time to report was observed. Introduction of RAST with automatic TLA imaging function could reduce time to report by 17:30 h. Excellent accordance between zone diameter and MIC results, particularly for cefoxitin, vancomycin and meropenem, was observed, but drawbacks due to ATU were seen.

13 April 2018 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
PDF file
SKSabrina Klein
Sabrina Klein
DNDennis Nurjadi
Dennis Nurjadi
SHSusanne Horner
Susanne Horner
KHKlaus Heeg
Klaus Heeg
SZStefan Zimmermann
Stefan Zimmermann
IBIrene Burckhardt
Irene Burckhardt
While total laboratory automation (TLA) is well established in laboratory medicine, only a few microbiological laboratories are using TLA systems. Especially in terms of speed and accuracy, working with TLA is expected to be superior to conventional microbiology. We compared in total 35,564 microbiological urine cultures with and without incubation and processing with BD Kiestra TLA for a 6-month period each retrospectively. Sixteen thousand three hundred thirty-eight urine samples were analyzed in the pre-TLA period and 19,226 with TLA. Sixty-two percent (n = 10,101/16338) of the cultures processed without TLA and 68% (n = 13,102/19226) of the cultures processed with TLA showed growth. There were significantly more samples with two or more species per sample and with low numbers of colony forming units (CFU) after incubation with TLA. Regarding the type of bacteria, there were comparable amounts of Enterobacteriaceae in the samples, slightly less non-fermenting Gram-negative bacteria, but significantly more Gram-positive cocci, and Gram-positive rods. Especially Alloscardivia omnicolens, Gardnerella vaginalis, Actinomyces spp., and Actinotignum schaalii were significantly more abundant in the samples incubated and processed with TLA. The time to report was significantly lower in the TLA processed samples by 1.5 h. We provide the first report in Europe of a large number of urine samples processed with TLA. TLA showed enhanced growth of non-classical and rarely cultured bacteria from urine samples. Our findings suggest that previously underestimated bacteria may be relevant pathogens for urinary tract infections. Further studies are needed to confirm our findings.